EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bisphenol A drives the comorbidity of non-alcoholic fatty liver disease and osteoarthritis by targeting RHOB: Integrated multi-omics, single-cell analysis, and experimental validation

Jingkai Di, Shuang Wang, Zijian Guo, Yijing Di, Nan Yang, Talante Juma, Yinqi Long, Likun Qi, Yongping Cao, Chuan Xiang

Experimental Gerontology · 2026

DOI: 10.1016/j.exger.2026.113242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Gerontology, 2026. Verfasst von Jingkai Di und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Second Hospital of Shanxi Medical University, Taiyuan, China; Department of Orthopedics, Peking University First Hospital,…. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Non-alcoholic Fatty Liver Disease, Phenols, Osteoarthritis. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: This study focuses on exploring the co-morbid mechanisms by which Bisphenol A (BPA) induces non-alcoholic fatty liver disease (NAFLD) and osteoarthritis (OA). METHOD: This study identified potential BPA targets utilizing the SwissTargetPrediction database. These targets were integrated with genes associated with NAFLD and OA, which were screened via Weighted Gene Co-expression Network Analysis and differential gene expression analysis. To elucidate the underlying biological mechanisms, functional enrichment and immune infiltration analyses were conducted. Core genes associated with comorbidity were pinpointed via machine learning. The interactions and cellular localization were further validated by molecular docking, molecular dynamics simulations, and single-cell transcriptomics. Finally, in vitro experiments were employed to verify the effects on chondrocyte function, and hepatic lipid metabolism. RESULTS: Functional enrichment analysis indicates that BPA-induced NAFLD and OA comorbidity pathways are enriched in muscle cell proliferation, DNA metabolism, and inflammation pathways. RHOB has been identified as a core gene, participating in disease progression by regulating signaling pathways such as Hippo and IL-17. Single-cell sequencing revealed that RHOB is primarily expressed in hepatocytes and cholangiocytes in NAFLD, while enriching in HomC and EC cell clusters in OA. In vitro experiments confirmed that BPA exposure suppresses RHOB expression, thereby promoting lipid accumulation in hepatocytes and impairing chondrocyte function. Concurrently, rescue experiments demonstrated that its overexpression significantly reversed these pathological states. CONCLUSION: BPA exposure drives the co-morbidity of OA and NAFLD by inhibiting RHOB. Consequently, limiting BPA exposure or modulating the RHOB pathway represents a viable approach for intervening in related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsNon-alcoholic Fatty Liver DiseasePhenolsOsteoarthritisBisphenol A CompoundsAnimalsSingle-Cell AnalysisLipid MetabolismMultiomicsHumansMolecular Docking SimulationComorbidityChondrocytes

Stichwörter der Autor:innen

Bisphenol AMolecular dockingMolecular dynamics simulationNetwork toxicologyNon-alcoholic fatty liver diseaseOsteoarthritis

Substanzen

Benzhydryl Compoundsbisphenol ABisphenol A CompoundsPhenols

Autor:innen und Institutionen

  • Department of Orthopedics, Second Hospital of Shanxi Medical University, Taiyuan, China; Department of Orthopedics, Peking University First Hospital, Beijing, China; Shanxi Provincial Key Laboratory of Bone and Soft Tis…
  • Department of Gastroenterology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China; Clinical School of The Second Peo…
  • Department of Orthopedics, Second Hospital of Shanxi Medical University, Taiyuan, China; Shanxi Provincial Key Laboratory of Bone and Soft Tissue Injury Repair, Taiyuan, China. Electronic address: sxyguozj@163.com.
  • First Hospital of Shanxi Medical University, Taiyuan, China. Electronic address: diyijing1@sxmu.edu.cn.
  • Department of Orthopedics, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China. Electronic address: nanyang0713@163.co…
  • Department of Orthopedics, Peking University First Hospital, Beijing, China. Electronic address: tazxzx@126.com.

Förderung

  • Science and Technology Development Fund

Zitieren

APA

Di, J., Wang, S., Guo, Z., Di, Y., Yang, N., Juma, T., Long, Y., Qi, L., Cao, Y., & Xiang, C. (2026). Bisphenol A drives the comorbidity of non-alcoholic fatty liver disease and osteoarthritis by targeting RHOB: Integrated multi-omics, single-cell analysis, and experimental validation. Experimental Gerontology. https://doi.org/10.1016/j.exger.2026.113242

Vancouver

Di J, Wang S, Guo Z, Di Y, Yang N, Juma T, et al. Bisphenol A drives the comorbidity of non-alcoholic fatty liver disease and osteoarthritis by targeting RHOB: Integrated multi-omics, single-cell analysis, and experimental validation. Experimental Gerontology. 2026. doi:10.1016/j.exger.2026.113242

BibTeX
@article{Di2026,
  author = {Di, Jingkai and Wang, Shuang and Guo, Zijian and Di, Yijing and Yang, Nan and Juma, Talante and Long, Yinqi and Qi, Likun and Cao, Yongping and Xiang, Chuan},
  title = {Bisphenol A drives the comorbidity of non-alcoholic fatty liver disease and osteoarthritis by targeting RHOB: Integrated multi-omics, single-cell analysis, and experimental validation},
  journal = {Experimental Gerontology},
  year = {2026},
  doi = {10.1016/j.exger.2026.113242}
}
Kostenlos starten →